The purpose of this study was to investigate the effects of poly(amidoamine) (PAMAM) dendrimers on ocular absorption of puerarin.
Methods:
The samples of rabbits' aqueous humor were collected by in vivo microdialysis. The ocular pharmacokinetic properties of puerarin were measured to evaluate the effects of PAMAM dendrimers on ocular absorption of puerarin.
Results:
In the pharmacokinetic studies, the AUC0∼∞ values of puerarin solution with 0.2% (w/v) PAMAM dendrimers (G3.0, G4.0, G5.0) were greater than those in the control group by 2.3-, 3.5-, and 2.1-folds, respectively. The Cmax values of puerarin solution with 0.2% (w/v) PAMAM dendrimers were 1.5, 2.5, and 1.3 times the values of the control group and the t1/2 values were significantly longer than that of control group.
Conclusions:
Using PAMAM dendrimers might be a promising strategy to enhance the absorption of puerarin. The generation of PAMAM dendrimers may play a key role in increasing the ocular absorption of puerarin.
Get full access to this article
View all access options for this article.
References
1.
UrttiA.Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv. Drug Deliv. Rev., 11:1131–1135. 2006.
2.
AliY., LehmussaariK.Industrial perspective in ocular drug delivery. Adv. Drug Deliv. Rev., 11:1258–1268. 2006.
3.
KompellaU.B., KadamR.S., LeeV.H.Recent advances in ophthalmic drug delivery. Ther. Deliv., 1:435–456. 2010.
4.
TomaliaD.A., BakerH., DewaldJ.R.et al.A new class of polymers: starburst dendritic molecules. Polym. J., 17:117–132. 1985.
5.
SvensonS., TomaliaD.A.Dendrimers in biomedical applications—reflections on the field. Adv. Drug Deliv. Rev., 15:2106–2129. 2005.
6.
HongS., BielinskaA.U., MeckeA.et al.Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug. Chem., 4:774–782. 2004.
7.
VenugantiV.V., PerumalO.P.Poly(amidoamine) dendrimers as skin penetration enhancers: influence of charge, generation, and concentration. J. Pharm. Sci., 7:2345–2356. 2009.
8.
VenugantiV.V., PerumalO.P.Effect of poly(amidoamine) (PAMAM) dendrimer on skin permeation of 5-fluorouracil. Int. J. Pharm., 1–2:230–238. 2008.
9.
VandammeT.F., BrobeckL.Poly(amidoamine) dendrimers as ophthalmic vehicles for ocular delivery of pilocarpine nitrate and tropicamide. J. Control. Release, 1:23–38. 2005.
10.
XuanB., ZhouY.H., YangR.L., LiN., MinZ.D., ChiouG.C.Improvement of ocular blood flow and retinal functions with puerarin analogs. J. Ocul. Pharmacol. Ther., 3:207–216. 1999.
11.
YueP.F., YuanH.L., LiX.Y., YangM., ZhuW.F., XiaoX.H.Development and optimization of intravenous puerarin emulsions formation by a novel complex-phase inversion-homogenization technology. Chem. Pharm. Bull (Tokyo)., 11:1563–1568. 2007.
12.
WuC.J., QiH.Y., ChenW.W.et al.Preparation and evaluation of a Carbopol/HPMC-based in situ gelling ophthalmic system for puerarin. Yakugaku. Zasshi., 1:183–191. 2007.
13.
YaoW.J., SunK.X., LiuY.et al.Effect of Poly (amidoamine) dendrimers on corneal penetration of puerarin. Biol. Pharm. Bull., 33:1371–1377. 2010.
14.
YaoW., SunK., MuH.et al.Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system. Drug Dev. Ind. Pharm., 36:1027–1035. 2010.
15.
CaoY., ZhangC., ShenW., ChengZ., YuL.L., PingQ.Poly(N-isopropylacrylamide)–chitosan as thermosensitive in situ gel-forming system for ocular drug delivery. J. Control. Release, 120:186–194. 2007.
16.
FuJ., FengX., YuanH.et al.Study of ocular pharmacokinetics of in situ gel system for S(−)-satropane evaluated by microdialysis. J. Pharm. Biomed. Anal., 48:840–843. 2008.
17.
TakR.V., PalD., GaoH., DeyS., MitraA.K.Transport of acyclovir ester prodrugs through rabbit cornea and SIRC-rabbit corneal epithelial cell line. J. Pharm. Sci., 9010:1505–1515. 2001.
18.
WeiG., DingP.T., ZhengJ.M., LuW.Y.Pharmacokinetics of timolol in aqueous humor sampled by microdialysis after topical administration of thermosetting gels. Biomed. Chromatogr., 20:67–71. 2006.
19.
KatragaddaS., GundaS., HariharanS., MitraA.K.Ocular pharmacokinetics of acyclovir amino acid ester prodrugs in the anterior chamber: evaluation of their utility in treating ocular HSV infections. Int. J. Pharm., 59:15–24. 2008.
20.
LiuZ., ZhangX., LiJ., LiuR., ShuL., JinL.Effects of Labrasol on the corneal drug delivery of baicalin. Drug Deliv., 16:399–404. 2009.
21.
LiuZ., YangX.G., LiX., PanW., LiJ.Study on the ocular pharmacokinetics of ion-activated in situ gelling ophthalmic delivery system for gatifloxacin by microdialysis. Drug Dev. Ind. Pharm., 33:1327–1331. 2007.
22.
LiX., NieS.F., KongJ., LiN., JuC.Y., PanW.S.A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers. Int. J. Pharm., 363:177–182. 2008.
23.
RittenhouseK.D., PeifferR.L.Jr., PollackG.M.Microdialysis evaluation of the ocular pharmacokinetics of propranolol in the conscious rabbite. Pharm. Res., 16:736–742. 1999.
24.
RittenhouseK.D., PeifferR.L.Jr., PollackG.M.Evaluation of microdialysis sampling of aqueous humor for in vivo models of ocular absorption and disposition1. J. Pharm. Biomed. Anal., 16:951–959. 1998.
25.
ZhangZ.Y., SmithB.D.High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. Bioconjug. Chem., 11:805–814. 2000.
26.
MalikN., WiwattanapatapeeR., KlopschR.et al.Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. J. Control. Release, 65:133–148. 2000.
